TrialThe Lancet. Respiratory medicine2017

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.

Nathan J Brendish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.